Cargando…

Concomitant diabetes with atrial fibrillation and anticoagulation management considerations

Atrial fibrillation is a highly prevalent cardiac arrhythmia. It is associated with numerous co mobilities. Approximately 30% of diabetic patients have atrial fibrillation and 15% of atrial fibrillation regulation patients have diabetes mellitus. Diabetes increases the likelihood of the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kreutz, Reinhold, Camm, A John, Rossing, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753879/ https://www.ncbi.nlm.nih.gov/pubmed/33380946 http://dx.doi.org/10.1093/eurheartj/suaa182

Ejemplares similares

Special considerations for therapeutic choice of non–vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
por: Okumura, Ken, et al.
Publicado: (2016)

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
por: Atterman, Adriano, et al.
Publicado: (2021)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
por: Atar, Dan, et al.
Publicado: (2020)

Managing atrial fibrillation in the global community: The European perspective
por: Kaba, Riyaz A, et al.
Publicado: (2013)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
por: Kirchhof, Paulus, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
por: Camm, A. John, et al.
Publicado: (2015)

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation
por: Poposka, Lidija, et al.
Publicado: (2016)

Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort
por: Said, Ahmad, et al.
Publicado: (2020)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management
por: Shamoun, Fadi, et al.
Publicado: (2015)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2020)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Cost considerations in the management of atrial fibrillation – impact of dronedarone
por: Khaykin, Yaariv, et al.
Publicado: (2012)

Atrial fibrillation in the elderly population: Challenges and management considerations
por: Salih, Mohammed, et al.
Publicado: (2021)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Persistent Atrial Fibrillation: The Role of Left Atrial Posterior Wall Isolation and Ablation Strategies
por: Kaba, Riyaz A., et al.
Publicado: (2021)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Ethnicity and anticoagulation management of hospitalized patients with atrial fibrillation in northwest China
por: Cheng, Xinchun, et al.
Publicado: (2017)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Risks and benefits of oral anticoagulants for stroke prophylaxis in atrial fibrillation according to body mass index: Nationwide cohort study of primary care records in England
por: Nakao, Yoko M., et al.
Publicado: (2022)

Management of Patients with Atrial Fibrillation: Specific Considerations for the Old Age
por: Haegeli, Laurent M., et al.
Publicado: (2011)

Anticoagulation for Stroke Prevention of Concomitant Atrial Fibrillation and End-Stage Renal Disease: Insights of Cardiologists and Nephrologists From India
por: ES, Swetha, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants
por: Wu, Victor Chien-Chia, et al.
Publicado: (2023)

Real-world clinical outcomes of oral anticoagulants among Japanese patients with atrial fibrillation and concomitant coronary artery disease
por: Chen, Yijiao, et al.
Publicado: (2023)

The use of anticoagulants in the management of atrial fibrillation among general practices in England
por: Cowan, Campbell, et al.
Publicado: (2013)

Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
por: Tan, Jian Liang, et al.
Publicado: (2018)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
por: Law, Mandy M., et al.
Publicado: (2023)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tugue86bmfo36av1jqpj4j1mn9